Unichem Laboratories Ltd
NSE: UNICHEMLAB BSE: 506690
₹346.20
(-1.18%)
Mon, 09 Mar 2026, 08:21 pm
Market Cap24.44B
PE Ratio8.28
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KUnichem Laboratories Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Unichem Laboratories's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- The company is paying a dividend however it is incurring a loss.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Unichem Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Unichem Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Unichem Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
- Unichem Laboratories has been profitable on average in the past, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 9.8x debt.
- Unichem Laboratories's cash and other short term assets cover its long term commitments.
- Unichem Laboratories's level of debt (7.3%) compared to net worth is satisfactory (less than 40%).
- Operating cash flow is negative therefore debt is not well covered.
- The level of debt compared to net worth has increased over the past 5 years (2.7% vs 7.3% today).
- High level of physical assets or inventory.
management
- The average tenure for the Unichem Laboratories board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- More shares have been bought than sold by Unichem Laboratories individual insiders in the past 3 months.
- The average tenure for the Unichem Laboratories management team is over 5 years, this suggests they are a seasoned and experienced team.
- Prakash's remuneration is higher than average for companies of similar size in India.
- Prakash's compensation has increased whilst company is loss making.
misc
- Unichem Laboratories is not covered by any analysts.
- Unichem Laboratories has significant price volatility in the past 3 months.
past
- Unable to compare Unichem Laboratories's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unichem Laboratories does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- It is difficult to establish if Unichem Laboratories has efficiently used its assets last year compared to the IN Pharmaceuticals industry average (Return on Assets) as it is loss-making.
- It is difficult to establish if Unichem Laboratories improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
- It is difficult to establish if Unichem Laboratories has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Unable to compare Unichem Laboratories's 1-year growth to the IN Pharmaceuticals industry average as it is not currently profitable.
value
- Unichem Laboratories is good value based on assets compared to the IN Pharmaceuticals industry average.
- UNICHEMLAB outperformed the Market in India which returned -14.5% over the past year.
- NSEI:UNICHEMLAB is up 17% outperforming the Pharmaceuticals industry which returned 6.8% over the past month.
- NSEI:UNICHEMLAB is up 17% outperforming the market in India which returned 8% over the past month.
- Unichem Laboratories's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Unichem Laboratories's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Unichem Laboratories is loss making, we can't compare its value to the IN Pharmaceuticals industry average.
- Unichem Laboratories is loss making, we can't compare the value of its earnings to the India market.
- UNICHEMLAB underperformed the Pharmaceuticals industry which returned 26.7% over the past year.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800